Bipolar Disorders

Shannon Aymes, MD

December 9, 2015

The unique biotypes may allow for more targeted treatments to be developed.

December 8, 2015

Further research will seek to determine if omega-3 fatty acids are a treatment target.

Haymarket Media

September 18, 2015

The FDA’s approval was based on data from controlled trials in adults with manic or mixed episodes of bipolar I disorder and schizophrenia.

June 3, 2015

Areas of the brain involved in emotional regulation impacted in adolescents with bipolar disorder.

Next post in Neurobehavioral Disorders

Pediatric Mental Health Treatment Increasing for Less Severe Symptoms